by further strengthening our pipeline and widening the availability of approved treatments for cancer

cancer patients in the US, battling cancer has not only been a health issue, but a considerable financial burden brought on by cancer treatment.
trident-inter.net/index.php/forum/welcom...t-kobe-uroflam-forum
Biosimilars are intended to be lower cost, high-quality treatment options that have the potential to alleviate such burden.
brawlstarsup.com/board/topic/apo-seleg-n...rnight/#postid-69094
We sincerely hope our trastuzumab biosimilar will do exactly that,” said Sang-Jin Pak, Senior Vice President and Head of Commercial Division, Samsung Bioepis. “At Samsung Bioepis, we will continue to demonstrate our enduring commitment to biosimilars
bbs.muanyun.com/forum.php?mod=viewthread&tid=5305&extra=